Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SCHUITEMAKER H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Messele, T; De Wit, TFR; Brouwer, M; Aklilu, M; Birru, T; Fontanet, AL; Schuitemaker, H; Hamann, D
      No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative ethiopian commercial sex workers and low-risk control subjects

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    2. Van Praag, RME; Prins, JM; Roos, MTL; Schellekens, PTA; Ten Berge, IJM; Yong, SL; Schuitemaker, H; Eerenberg, AJM; Jurriaans, S; De Wolf, F; Fox, CH; Goudsmit, J; Miedema, F; Lange, JMA
      OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion

      JOURNAL OF CLINICAL IMMUNOLOGY
    3. Vyakarnam, A; Eyeson, J; Teo, I; Zuckerman, M; Babaahmady, K; Schuitemaker, H; Shaunak, S; Rostron, T; Rowland-Jones, S; Simmons, G; Clapham, P
      Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells

      AIDS
    4. Reijers, MHE; Weverling, GJ; Jurriaans, S; Roos, MTL; Wit, FWNM; Weigel, HM; Ten Kate, RW; Mulder, JW; Richter, C; Ter Hofstede, HJM; Sprenger, H; Hoetelmans, RMW; Schuitemaker, H; Lange, JMA
      The ADAM study continued: maintenance therapy after 50 weeks of induction therapy

      AIDS
    5. Beaumont, T; van Nuenen, A; Broersen, S; Blattner, WA; Lukashov, VV; Schuitemaker, H
      Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course

      JOURNAL OF VIROLOGY
    6. Kwa, D; Vingerhoed, J; Boeser-Nunnink, B; Broersen, S; Schuitemaker, H
      Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)T-cell subsets are determined only by coreceptor expression

      JOURNAL OF VIROLOGY
    7. Kreisberg, JF; Kwa, D; Schramm, B; Trautner, V; Connor, R; Schuitemaker, H; Mullins, JI; van't Wout, AB; Goldsmith, MA
      Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status

      JOURNAL OF VIROLOGY
    8. Koning, FA; Schols, D; Schuitemaker, H
      No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    9. Hazenberg, MD; Hamann, D; Schuitemaker, H; Miedema, F
      T cell depletion in HIV-I infection: how CD4(+) T cells go out of stock

      NATURE IMMUNOLOGY
    10. Maas, JJJ; Gange, SJ; Schuitemaker, H; Coutinho, RA; van Leeuwen, R; Margolick, JB
      Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study

      AIDS
    11. Kostense, S; Krop, E; Blaak, H; Schuitemaker, H; Miedema, F
      Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants

      AIDS
    12. Putter, H; Prins, JM; Jurriaans, S; Roos, M; Ferguson, NM; van Praag, R; van der Hoek, L; Schuitemaker, H; Anderson, RM; Goudsmit, J; Lange, JMA; de Wolf, F
      Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection

      AIDS
    13. Reijers, MHE; Weigel, HM; Hart, AAM; Ten Kate, RW; Mulder, JW; Reiss, P; Schuitemaker, H; Hoetelmans, RMW; Weverling, GJ; Lange, JMA
      Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study

      AIDS
    14. Blaak, H; Ran, LJ; Rientsma, R; Schuitemaker, H
      Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production

      VIROLOGY
    15. Blaak, H; van't Wout, AB; Brouwer, M; Hooibrink, B; Hovenkamp, E; Schuitemaker, H
      In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    16. Scoggins, RM; Taylor, JR; Patrie, J; van't Wout, AB; Schuitemaker, H; Camerini, D
      Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice

      JOURNAL OF VIROLOGY
    17. Kootstra, NA; Zwart, BM; Schuitemaker, H
      Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of thecell cycle

      JOURNAL OF VIROLOGY
    18. Beaumont, T; Broersen, S; van Nuenen, AD; Huisman, HG; Husman, AMD; Heeney, JL; Schuitemaker, H
      Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees

      JOURNAL OF VIROLOGY
    19. van Rij, RP; Blaak, H; Visser, JA; Brouwer, M; Rientsma, R; Broersen, S; Husman, AMD; Schuitemaker, H
      Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

      JOURNAL OF CLINICAL INVESTIGATION
    20. van Rij, RP; Blaak, H; Visser, JA; Brouwer, M; Rientsma, R; Broersen, S; Husman, AMD; Schuitemaker, H
      Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000)

      JOURNAL OF CLINICAL INVESTIGATION
    21. Meyer, L; Magierowska, M; Hubert, JB; Theodorou, I; van Rij, R; Prins, M; Husman, AMD; Coutinho, R; Schuitemaker, H
      CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients

      AIDS
    22. Prins, JM; Jurriaans, S; van Praag, RME; Blaak, H; van Rij, R; Schellekens, PTA; ten Berge, IJM; Yong, SL; Fox, CH; Roos, MTL; de Wolf, F; Goudsmit, J; Schuitemaker, H; Lange, JMA
      Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

      AIDS
    23. Abebe, A; Demissie, D; Goudsmit, J; Brouwer, M; Kuiken, CL; Pollakis, G; Schuitemaker, H; Fontanet, AL; de Wit, TFR
      HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

      AIDS
    24. Kootstra, NA; Schuitemaker, H
      Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages

      VIROLOGY
    25. Berkowitz, RD; van't Wout, AB; Kootstra, NA; Moreno, ME; Linquist-Stepps, VD; Bare, C; Stoddart, CA; Schuitemaker, H; McCune, JM
      R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus

      JOURNAL OF VIROLOGY
    26. Husman, AMD; van Rij, RP; Blaak, H; Broersen, S; Schuitemaker, H
      Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

      JOURNAL OF INFECTIOUS DISEASES
    27. van Rij, RP; Portegies, P; Hallaby, T; Lange, JMA; Visser, J; Husman, AMD; van't Wout, AB; Schuitemaker, H
      Reduced prevalence of the CCR5 Delta 32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex

      JOURNAL OF INFECTIOUS DISEASES
    28. Koot, M; van Leeuwen, R; de Goede, REY; Keet, IPM; Danner, S; Schattenkerk, JKME; Reiss, P; Tersmette, M; Lange, JMA; Schuitemaker, H
      Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis

      JOURNAL OF INFECTIOUS DISEASES
    29. Husman, AD; Blaak, H; Brouwer, M; Schuitemaker, H
      CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection

      JOURNAL OF IMMUNOLOGY
    30. Abebe, A; Demissie, D; Goudsmit, J; Brouwer, M; Kuiken, CL; Pollakis, G; Schuitemaker, H; Fontanet, AL; de Wit, TFR
      HIV-1 subtype C syncytium- and non-syncytium-Ethiopian patients with AIDS

      ETHIOPIAN MEDICAL JOURNAL
    31. Bos, OJM; Sunye, DGJ; Nieuweboer, CEF; van Engelenburg, FAC; Schuitemaker, H; Over, J
      Virus validation of pH 4-treated human immunoglobulin products produced bythe Cohn fractionation process

      BIOLOGICALS
    32. KOOTSTRA NA; SCHUITEMAKER H
      PROLIFERATION-DEPENDENT REPLICATION IN PRIMARY MACROPHAGES OF MACROPHAGE-TROPIC HIV TYPE-1 VARIANTS

      AIDS research and human retroviruses
    33. VANRIJ RP; BROERSEN S; GOUDSMIT J; COUTINHO RA; SCHUITEMAKER H
      THE ROLE OF A STROMAL CELL-DERIVED FACTOR-I CHEMOKINE GENE VARIANT INTHE CLINICAL COURSE OF HIV-1 INFECTION

      AIDS
    34. MASS J; HUSMAN AMD; BROUWER M; KROL A; COUTINHO R; KEET I; VANLEEUWEN R; SCHUITEMAKER H
      PRESENCE OF THE VARIANT MANNOSE-BINDING LECTIN ALLELES ASSOCIATED WITH SLOWER PROGRESSION TO AIDS

      AIDS
    35. HOETELMANS RMW; REIJERS MHE; WEVERLING GJ; TENKATE RW; WIT FWNM; MULDER JW; WEIGEL HM; FRISSEN PHJ; ROOS M; JURRIAANS S; SCHUITEMAKER H; DEWOLF F; BEIJNEN JH; LANGE JMA
      THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY

      AIDS
    36. WEVERLING GJ; LANGE JMA; JURRIAANS S; PRINS JM; LUKASHOV VV; NOTERMANS DW; ROOS M; SCHUITEMAKER H; HOETELMANS RMW; DANNER SA; GOUDSMIT J; DEWOLF F
      ALTERNATIVE MULTIDRUG REGIMEN PROVIDES IMPROVED SUPPRESSION OF HIV-1 REPLICATION OVER TRIPLE THERAPY

      AIDS
    37. WOUT ABVT; RAN LJ; NIJHUIS M; TIJNAGEL JMGH; DEGROOT T; VANLEEUWEN R; BOUCHER CAB; SCHUITEMAKER H; SCHUURMAN R
      EFFICIENT INHIBITION OF BOTH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING WILD-TYPE HIV-1 BY LAMIVUDINE IN-VIVO

      AIDS
    38. WOLTHERS KC; SCHUITEMAKER H; MIEDEMA F
      RAPID CD4(-CELL TURNOVER IN HIV-1 INFECTION - A PARADIGM REVISITED() T)

      Immunology today
    39. REIJERS MHE; WEVERLING GJ; JURRIAANS S; WIT FWNM; WEIGEL HM; TENKATE RW; MULDER JW; FRISSEN PHJ; VANLEEUWEN R; REISS P; SCHUITEMAKER H; DEWOLF F; LANGE JMA
      MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY

      Lancet
    40. BERGER EA; DOMS RW; FENYO EM; KORBER BTM; LITTMAN DR; MOORE JP; SATTENTAU QJ; SCHUITEMAKER H; SODROSKI J; WEISS RA
      A NEW CLASSIFICATION FOR HIV-1

      Nature
    41. VANTWOUT AB; BLAAK H; RAN LJ; BROUWER M; KUIKEN C; SCHUITEMAKER H
      EVOLUTION OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING BIOLOGICALVIRUS CLONES IN RELATION TO REPLICATION KINETICS DURING THE COURSE OFHUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      Journal of virology
    42. BLAAK H; VANTWOUT AB; BROUWER M; CORNELISSEN M; KOOTSTRA NA; ALBRECHTVANLENT N; KEET RPM; GOUDSMIT J; COUTINHO RA; SCHUITEMAKER H
      INFECTIOUS CELLULAR LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED INDIVIDUALS AND SUSCEPTIBILITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM THEIR EXPOSED PARTNERS TO NON-SYNCYTIUM-INDUCING HIV-1AS MAJOR DETERMINANTS FOR HIV-1 TRANSMISSION IN HOMOSEXUAL COUPLES

      Journal of virology
    43. VANTWOUT AB; RAN LJ; KUIKEN CL; KOOTSTRA NA; PALS ST; SCHUITEMAKER H
      ANALYSIS OF THE TEMPORAL RELATIONSHIP BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 QUASI-SPECIES IN SEQUENTIAL BLOOD-SAMPLES AND VARIOUS ORGANS OBTAINED AT AUTOPSY

      Journal of virology
    44. PONTESILLI O; KLEIN MR; KERKHOFGARDE SR; PAKKER NG; DEWOLF F; SCHUITEMAKER H; MIEDEMA F
      LONGITUDINAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFICCYTOTOXIC T-LYMPHOCYTE RESPONSES - A PREDOMINANT GAG-SPECIFIC RESPONSE IS ASSOCIATED WITH NONPROGRESSIVE INFECTION

      The Journal of infectious diseases
    45. SPIJKERMAN I; DEWOLF F; LANGENDAM M; SCHUITEMAKER H; COUTINHO R
      EMERGENCE OF SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS COINCIDES WITH A TRANSIENT INCREASE IN VIRAL-RNA LEVEL AND IS AN INDEPENDENT PREDICTOR FOR PROGRESSION TO AIDS

      The Journal of infectious diseases
    46. BLAAK H; BROUWER M; RAN LJ; DEWOLF F; SCHUITEMAKER H
      IN-VITRO REPLICATION KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) VARIANTS IN RELATION TO VIRUS LOAD IN LONG-TERM SURVIVORS OF HIV-1 INFECTION

      The Journal of infectious diseases
    47. van Rij, RP; Husman, AMD; Brouwer, M; Goudsmit, J; Coutinho, RA; Schuitemaker, H
      Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) ornon-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants

      JOURNAL OF INFECTIOUS DISEASES
    48. Bogers, WMJM; Koornstra, WH; Dubbes, RH; ten Haaft, PJF; Verstrepen, BE; Jhagjhoorsingh, SS; Haaksma, AGM; Niphuis, H; Laman, JD; Norley, S; Schuitemaker, H; Goudsmit, J; Hunsmann, G; Heeney, JL; Wigzell, H
      Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees

      JOURNAL OF GENERAL VIROLOGY
    49. SCHUITEMAKER H; HUSMAN AMD
      CCR5 GENOTYPE AND THE CLINICAL COURSE OF HIV-1 INFECTION - IN RESPONSE

      Annals of internal medicine
    50. KOOTSTRA NA; MIEDEMA F; SCHUITEMAKER H
      ANALYSIS OF CD8(-LYMPHOCYTE-MEDIATED NONLYTIC SUPPRESSION OF AUTOLOGOUS AND HETEROLOGOUS PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES() T)

      AIDS research and human retroviruses
    51. GROENINK M; SWART PJ; BROERSEN S; KUIPERS M; MEIJER DKF; SCHUITEMAKER H
      POTENT INHIBITION OF REPLICATION OF PRIMARY HIV TYPE-1 ISOLATES IN PERIPHERAL-BLOOD LYMPHOCYTES BY NEGATIVELY CHARGED HUMAN SERUM ALBUMINS

      AIDS research and human retroviruses
    52. PONTESILLI O; KLEIN MR; KERKHOFGARDE SR; PAKKER NG; DEWOLF F; SCHUITEMAKER H; MIEDEMA F
      KINETICS OF IMMUNE FUNCTIONS AND VIRUS-REPLICATION DURING HIV-1 INFECTION

      Immunology letters
    53. BLAAK H; DEWOLF F; VANTWOUT AB; PAKKER NG; BAKKER M; GOUDSMIT J; SCHUITEMAKER H
      TEMPORAL RELATIONSHIP BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNALEVELS IN SERUM AND CELLULAR INFECTIOUS LOAD IN PERIPHERAL-BLOOD

      The Journal of infectious diseases
    54. VANTWOUT AB; RAN LJ; DEJONG MD; BAKKER M; VANLEEUWEN R; NOTERMANS DW; LOELIGER AE; DEWOLF F; DANNER SA; REISS P; BOUCHER CAB; LANGE JMA; SCHUITEMAKER H
      SELECTIVE-INHIBITION OF SYNCYTIUM-INDUCING AND NONSYNCYTIUM-INDUCING HIV-1 VARIANTS IN INDIVIDUALS RECEIVING DIDANOSINE OR ZIDOVUDINE, RESPECTIVELY

      The Journal of clinical investigation
    55. HUSMAN AMD; KOOT M; CORNELISSEN M; KEET IPM; BROUWER M; BROERSEN SM; BAKKER M; ROOS MTL; PRINS M; DEWOLF F; COUTINHO RA; MIEDEMA F; GOUDSMIT J; SCHUITEMAKER H
      ASSOCIATION BETWEEN CCR5 GENOTYPE AND THE CLINICAL COURSE OF HIV-1 INFECTION

      Annals of internal medicine
    56. KOOT M; VANTWOUT AB; MIEDEMA F; SCHUITEMAKER H
      USE OF IMMUNOLOGICAL AND VIRAL PARAMETERS TO PREDICT PROGRESSION OF HIV-INFECTION DURING NATURAL COURSE AND ANTIRETROVIRAL TREATMENT

      Biodrugs
    57. KUIPERS ME; HUISMAN JG; SWART PJ; DEBETHUNE MP; PAUWELS R; SCHUITEMAKER H; DECLERCQ E; MEIJER DKF
      MECHANISM OF ANTI-HIV ACTIVITY OF NEGATIVELY CHARGED ALBUMINS - BIOMOLECULAR INTERACTION WITH THE HIV-1 ENVELOPE PROTEIN GP120

      Journal of acquired immune deficiency syndromes and human retrovirology
    58. SWART PJ; BELJAARS E; SMIT C; PASMA A; SCHUITEMAKER H; MEIJER DKF
      COMPARATIVE PHARMACOKINETIC, IMMUNOLOGICAL AND HEMATOLOGIC STUDIES ONTHE ANTI-HIV-1 2 COMPOUNDS ACONITYLATED AND SUCCINYLATED HSA/

      Journal of drug targeting.
    59. FOUCHIER RAM; MEYAARD L; BROUWER M; HOVENKAMP E; SCHUITEMAKER H
      BROADER TROPISM AND HIGHER CYTOPATHICITY FOR CD4(-CELLS OF A SYNCYTIUM-INDUCING COMPARED TO A NON-SYNCYTIUM-INDUCING HIV-1 ISOLATE AS A MECHANISM FOR ACCELERATED CD4(+) T-CELL DECLINE IN-VIVO() T)

      Virology
    60. VANTWOUT AB; DEJONG MD; KOOTSTRA NA; VEENSTRA J; LANGE JMA; BOUCHER CAB; SCHUITEMAKER H
      CHANGES IN CELLULAR VIRUS LOAD AND ZIDOVUDINE RESISTANCE OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS POPULATIONS UNDER ZIDOVUDINE PRESSURE - A CLONAL ANALYSIS

      The Journal of infectious diseases
    61. KOOT M; VANTWOUT AB; KOOTSTRA NA; DEGOEDE REY; TERSMETTE M; SCHUITEMAKER H
      RELATION BETWEEN CHANGES IN CELLULAR LOAD, EVOLUTION OF VIRAL PHENOTYPE, AND THE CLONAL COMPOSITION OF VIRUS POPULATIONS IN THE COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      The Journal of infectious diseases
    62. FOUCHIER RAM; SCHUITEMAKER H
      MOLECULAR DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I PHENOTYPE VARIABILITY

      European journal of clinical investigation
    63. VANTWOUT AB; DEJONG MD; KOOTSTRA NA; SCHUURMAN R; COUTINHO R; BOUCHER CAB; SCHUITEMAKER H
      PREFERENTIAL INHIBITION OF NON-SYNCYTIUM-INDUCING HIV-1 VARIANTS BY ZIDOVUDINE

      Journal of acquired immune deficiency syndromes and human retrovirology
    64. VEENSTRA J; SCHUURMAN R; CORNELISSEN M; VANTWOUT AB; BOUCHER CAB; SCHUITEMAKER H; GOUDSMIT J; COUTINHO RA
      TRANSMISSION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS FOLLOWING DELIBERATE INJECTION OF BLOOD FROM A PATIENT WITH AIDS - CHARACTERISTICS AND NATURAL-HISTORY OF THE VIRUS

      Clinical infectious diseases
    65. FOUCHIER RAM; BROERSEN SM; BROUWER M; TERSMETTE M; VANTWOUT AB; GROENINK M; SCHUITEMAKER H
      TEMPORAL RELATIONSHIP BETWEEN ELONGATION OF THE HIV TYPE-1 GLYCOPROTEIN-120 V2 DOMAIN AND THE CONVERSION TOWARD A SYNCYTIUM-INDUCING PHENOTYPE

      AIDS research and human retroviruses
    66. GUILLON C; BEDIN F; FOUCHIER RAM; SCHUITEMAKER H; GRUTERS RA
      COMPLETION OF NUCLEOTIDE-SEQUENCES OF NON-SYNCYTIUM-INDUCING AND SYNCYTIUM-INDUCING HIV TYPE-1 VARIANTS ISOLATED FROM THE SAME PATIENT

      AIDS research and human retroviruses
    67. MIEDEMA F; MEYAARD L; FOUCHIER RAM; OTTO SA; BROUWER M; HOVENKAMP E; SCHUITEMAKER H
      VIRO-IMMUNOLOGY OF HIV-INFECTION - TH CYTOKINES AND HIV REPLICATION

      AIDS research and human retroviruses
    68. SCHUITEMAKER H; VANTWOUT AB; KOOT M; FOUCHIER RAM; MEYAARD L; MIEDEMA F
      KINETICS OF NSI AND SI VIRAL POPULATIONS IN THE NATURAL COURSE OF INFECTION AND ZIDOVUDINE TREATED INDIVIDUALS

      Journal of cellular biochemistry
    69. KOOTSTRA NA; VANTWOUT AB; HUISMAN HG; MIEDEMA F; SCHUITEMAKER H
      INTERFERENCE OF INTERLEUKIN-10 WITH HIV-1 REPLICATION IN PRIMARY MONOCYTE-DERIVED MACROPHAGES

      Journal of cellular biochemistry
    70. DSOUZA MP; MILMAN G; BRADAC JA; MCPHEE D; HANSON CV; HENDRY RM; CORCORAN T; STOTT J; FUNG M; HANSON C; LAMAN J; MASCOLA J; MCPHEE D; RASHEED S; RICHMAN D; SCHUITEMAKER H; THIRIART C; WAINBERG M; WEBER J; BEDDOWS S; TILLEY S; ROBINSON J; ZOLLAPAZNER S; KATINGER H; CUMMINS L
      NEUTRALIZATION OF PRIMARY HIV-1 ISOLATES BY ANTI-ENVELOPE MONOCLONAL-ANTIBODIES

      AIDS
    71. SCHUITEMAKER H; MIEDEMA F
      UNTITLED - COMMENT

      Immunology today
    72. FOUCHIER RAM; BROUWER M; BROERSEN SM; SCHUITEMAKER H
      SIMPLE DETERMINATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNCYTIUM-INDUCING V3 GENOTYPE BY PCR

      Journal of clinical microbiology
    73. SCHUITEMAKER H; FOUCHIER RAM; BROERSEN S; GROENINK M; KOOT M; VANTWOUT AB; HUISMAN HG; TERSMETTE M; MIEDEMA F
      ENVELOPE V2 CONFIGURATION AND HIV-1 PHENOTYPE - CLARIFICATION

      Science
    74. WRIN T; LOH TP; VENNARI JC; SCHUITEMAKER H; NUNBERG JH
      ADAPTATION TO PERSISTENT GROWTH IN THE H9 CELL-LINE RENDERS A PRIMARYISOLATE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SENSITIVE TO NEUTRALIZATION BY VACCINE SERA

      Journal of virology
    75. GROENINK M; MOORE JP; BROERSEN S; SCHUITEMAKER H
      EQUAL LEVELS OF GP120 RETENTION AND NEUTRALIZATION RESISTANCE OF PHENOTYPICALLY DISTINCT PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS UPON SOLUBLE CD4 TREATMENT

      Journal of virology
    76. KLEIN MR; VANBAALEN CA; HOLWERDA AM; GARDE SRK; BENDE RJ; KEET IPM; EEFTINCKSCHATTENKERK JKM; OSTERHAUS ADME; SCHUITEMAKER H; MIEDEMA F
      KINETICS OF GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES DURING THE CLINICAL COURSE OF HIV-1 INFECTION - A LONGITUDINAL ANALYSIS OF RAPID PROGRESSORS AND LONG-TERM ASYMPTOMATICS

      The Journal of experimental medicine
    77. SCHUITEMAKER H
      IL4 AND IL10 AS POTENT INHIBITORS OF HIV-1 REPLICATION IN MACROPHAGESIN-VITRO - A ROLE FOR CYTOKINES IN THE IN-VIVO VIRUS HOST-RANGE

      Research in immunology
    78. SCHUITEMAKER H
      IL4 AND IL10 AS POTENT INHIBITORS OF HIV-1 REPLICATION IN MACROPHAGESIN-VITRO - A ROLE FOR CYTOKINES IN THE IN-VIVO VIRUS HOST-RANGE - FINAL STATEMENT

      Research in immunology
    79. MIEDEMA F; MEYAARD L; OTTO SA; KEET IPM; HEENY JL; KOOTSTRA NA; SCHUITEMAKER H
      TH1 DYSFUNCTION, PROGRAMMED T-CELL DEATH AND PREFERENTIAL OUTGROWTH OF TH2 CELLS - CORRELATION WITH HIV-INFECTION OF MONOCYTES

      AIDS research and human retroviruses
    80. SCHUITEMAKER H
      MACROPHAGE-TROPIC HIV-1 VARIANTS - INITIATORS OF INFECTION AND AIDS PATHOGENESIS

      Journal of leukocyte biology
    81. DSOUZA MP; GEYER SJ; HANSON CV; HENDRY RM; MILMAN G; CHAMOW S; FUNG M; GEYER S; HAIGWOOD N; HANSON C; HENDRY M; HATTORI T; HUISMAN H; SCHUITEMAKER H; KATINGER H; KLIKS S; LEVY J; LAMAN J; LANGEDIJK H; MELOEN R; MCPHEE D; MITCHELL W; NARA P; PAGE M; LING C; PINTER A; POSNER M; POTTS B; FIELD K; RICHMAN D; ROBINSON J; STEIMER K; STOTT J; CORCORAN T; THIRIART C; WAHREN B; WAINBERG M; WEBER J; ZOLLAPAZNER S; BUCHINDER A
      EVALUATION OF MONOCLONAL-ANTIBODIES TO HIV-1 ENVELOPE BY NEUTRALIZATION AND BINDING ASSAYS - AN INTERNATIONAL COLLABORATION

      AIDS
    82. ROOS MTL; DELEEUW NASM; CLAESSEN FAP; HUISMAN HG; KOOTSTRA NA; MEYAARD L; SCHELLEKENS PTA; SCHUITEMAKER H; MIEDEMA F
      VIRO-IMMUNOLOGICAL STUDIES IN ACUTE HIV-1 INFECTION

      AIDS
    83. ROOS MTL; DELEEUW NASM; CLAESSEN FAP; HUISMAN HG; KOOTSTRA NA; MEYAARD L; SCHELLEKENS PTA; SCHUITEMAKER H; MIEDEMA F
      VIRO-IMMUNOLOGICAL STUDIES IN ACUTE HIV-1 INFECTION

      AIDS
    84. SCHUITEMAKER H; KOOTSTRA NA; FOUCHIER RAM; HOOIBRINK B; MIEDEMA F
      PRODUCTIVE HIV-1 INFECTION OF MACROPHAGES RESTRICTED TO THE CELL FRACTION WITH PROLIFERATIVE CAPACITY

      EMBO journal
    85. MIEDEMA F; MEYAARD L; KOOT M; KLEIN MR; ROOS MTL; GROENINK M; FOUCHIER RAM; VANTWOUT AB; TERSMETTE M; SCHELLEKENS PTA; SCHUITEMAKER H
      CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION

      Immunological reviews
    86. SCHUITEMAKER H; KOOT M; MIEDEMA F
      RECENT DEVELOPMENT ON RESEARCH IN AIDS PATHOGENESIS

      Vox sanguinis
    87. JURRIAANS S; VANGEMEN B; WEVERLING GJ; VANSTRIJP D; NARA P; COUTINHO R; KOOT M; SCHUITEMAKER H; GOUDSMIT J
      THE NATURAL-HISTORY OF HIV-1 INFECTION - VIRUS LOAD AND VIRUS PHENOTYPE INDEPENDENT DETERMINANTS OF CLINICAL COURSE

      Virology
    88. KOOTSTRA NA; VANTWOUT AB; HUISMAN HG; MIEDEMA F; SCHUITEMAKER H
      INTERFERENCE OF INTERLEUKIN-10 WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY MONOCYTE-DERIVED MACROPHAGES

      Journal of virology
    89. SCHUITEMAKER H; MIEDEMA F
      CAPACITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO INFECT CHIMPANZEE MONOCYTES IN-VITRO - REPLY

      The Journal of infectious diseases
    90. FOUCHIER RAM; BROUWER M; KOOTSTRA NA; HUISMAN HG; SCHUITEMAKER H
      HIV-1 MACROPHAGE TROPISM IS DETERMINED AT MULTIPLE LEVELS OF THE VIRAL REPLICATION CYCLE

      The Journal of clinical investigation
    91. VANTWOUT AB; KOOTSTRA NA; MULDERKAMPINGA GA; ALBRECHTVANLENT N; SCHERPBIER HJ; VEENSTRA J; BOER K; COUTINHO RA; MIEDEMA F; SCHUITEMAKER H
      MACROPHAGE-TROPIC VARIANTS INITIATE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AFTER SEXUAL, PARENTERAL, AND VERTICAL TRANSMISSION

      The Journal of clinical investigation
    92. SCHUITEMAKER H; GROENINK M; MEYAARD L; KOOTSTRA NA; FOUCHIER RAM; GRUTERS RA; HUISMAN HG; TERSMETTE M; MIEDEMA F
      EARLY REPLICATION STEPS BUT NOT CELL-TYPE-SPECIFIC SIGNALING OF THE VIRAL LONG TERMINAL REPEAT DETERMINE HIV-1 MONOCYTOTROPISM

      AIDS research and human retroviruses
    93. SCHUITEMAKER H; TERSMETTE M; KOOT M; GROENINK M; FOUCHIER RAM; MEYAARD L; HUISMAN H; MIEDEMA F
      MOLECULAR-BIOLOGY AND CLINICAL-SIGNIFICANCE OF HIV-1 BIOLOGICAL PHENOTYPE

      Journal of cellular biochemistry
    94. GROENINK M; FOUCHIER RAM; BROERSEN S; BAKER CH; VANDERJAGT RCM; MIEDEMA F; HUISMAN HG; TERSMETTE M; SCHUITEMAKER H
      ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY

      Journal of cellular biochemistry
    95. TERSMETTE M; SCHUITEMAKER H
      VIRULENT HIV STRAINS

      AIDS
    96. MEYAARD L; SCHUITEMAKER H; MIEDEMA F
      T-CELL DYSFUNCTION IN HIV-INFECTION - ANERGY DUE TO DEFECTIVE ANTIGEN-PRESENTING CELL-FUNCTION

      Immunology today
    97. GROENINK M; FOUCHIER RAM; BROERSEN S; BAKER CH; KOOT M; VANTWOUT AB; HUISMAN HG; MIEDEMA F; TERSMETTE M; SCHUITEMAKER H
      RELATION OF PHENOTYPE EVOLUTION OF HIV-1 TO ENVELOPE V2 CONFIGURATION

      Science
    98. SCHUITEMAKER H; MEYAARD L; KOOTSTRA NA; DUBBES R; OTTO SA; TERSMETTE M; HEENEY JL; MIEDEMA F
      LACK OF T-CELL DYSFUNCTION AND PROGRAMMED CELL-DEATH IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED CHIMPANZEES CORRELATES WITH ABSENCE OFMONOCYTOTROPIC VARIANTS

      The Journal of infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 11:58:22